Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
While GLP-1 agonists may produce greater total weight loss, AOD-9604 more selectively targets fat tissue while preserving muscle mass
Some clinics offer them for weight loss
Your safety and comfort are our top priorities
Preclinical studies investigating BPC-157 in inflammatory bowel disease models report modulation of inflammatory signaling, stabilization of intestinal microvasculature, and preservation of mucosal
While some patients have reported weight loss, these effects vary from person to person and are not guaranteed
The SURPASS program (for type 2 diabetes) and SURMOUNT program (for obesity) together enrolled over 20,000 participants across multiple Phase III trials
US$ 25.99
US$ 26.45
US$ 20.86
US$ 22.46
US$ 22.91
US$ 27.92
US$ 29.50
US$ 28.49
US$ 28.17
US$ 20.00
